APO Research
Talk to an analyst

APO RESEARCH · REPORT

Topical Drugs CDMO

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Topical Drugs CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025194 pages

Choose your research edition.

Industry ResearchTopical Drugs CDMO Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Topical Drugs CDMO Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Topical Drugs CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Topical Drugs CDMO Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Topical Drugs CDMO Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Topical Drugs CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Topical Drugs CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Topical Drugs CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Topical Drugs CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Topical Drugs CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Topical Drugs CDMO include Ascendia Pharmaceuticals, Bora Pharmaceutical CDMO, Cambrex Corporation, Contract Pharmaceuticals Limited, DPT Laboratories LTD., Lubrizol Life Science, MedPharm Ltd., PCI Pharma Services and Pierre Fabre Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Topical Drugs CDMO market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Topical Drugs CDMO and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Topical Drugs CDMO revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Topical Drugs CDMO market size, projected growth trends, production technologies, key applications, and end-use industries.

Topical Drugs CDMO Segment by Company

Ascendia Pharmaceuticals

Bora Pharmaceutical CDMO

Cambrex Corporation

Contract Pharmaceuticals Limited

DPT Laboratories LTD.

Lubrizol Life Science

MedPharm Ltd.

PCI Pharma Services

Pierre Fabre Group

Piramal Pharma Solutions

Topical Drugs CDMO Segment by Type

Contract Development

Contract Manufacturing

Topical Drugs CDMO Segment by Application

Semi-Solid Formulations

Solid Formulations

Liquid Formulations

Others

Topical Drugs CDMO Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Drugs CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Topical Drugs CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Drugs CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Topical Drugs CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Topical Drugs CDMO industry.

Chapter 3: Detailed analysis of Topical Drugs CDMO companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Topical Drugs CDMOrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Topical Drugs CDMO Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Contract Development Table 3. Key Players of Contract Manufacturing Table 4. Global Topical Drugs CDMO Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Semi-Solid Formulations Table 6. Key Players of Solid Formulations Table 7. Key Players of Liquid Formulations Table 8. Key Players of Others Table 9. Global Topical Drugs CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Topical Drugs CDMO Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Topical Drugs CDMO Market Share by Region (2021-2026) Table 12. Global Topical Drugs CDMO Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Topical Drugs CDMO Market Share by Region (2027-2032) Table 14. Topical Drugs CDMO Industry Trends Table 15. Topical Drugs CDMO Industry Drivers Table 16. Topical Drugs CDMO Industry Opportunities and Challenges Table 17. Topical Drugs CDMO Industry Restraints Table 18. Global Topical Drugs CDMO Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Topical Drugs CDMO Revenue Market Share by Company (2021-2026) Table 20. Global Topical Drugs CDMO Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Topical Drugs CDMO Key Company Head Office and Area Served Table 22. Global Topical Drugs CDMO Company, Product Type & Application Table 23. Global Topical Drugs CDMO Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Topical Drugs CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Topical Drugs CDMO Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Topical Drugs CDMO Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Topical Drugs CDMO Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Topical Drugs CDMO Revenue Market Share by Type (2021-2026) Table 30. Global Topical Drugs CDMO Revenue Market Share by Type (2027-2032) Table 31. Global Topical Drugs CDMO Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Topical Drugs CDMO Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Topical Drugs CDMO Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Topical Drugs CDMO Revenue Market Share by Application (2021-2026) Table 35. Global Topical Drugs CDMO Revenue Market Share by Application (2027-2032) Table 36. Ascendia Pharmaceuticals Company Information Table 37. Ascendia Pharmaceuticals Business Overview Table 38. Ascendia Pharmaceuticals Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Ascendia Pharmaceuticals Topical Drugs CDMO Product Portfolio Table 40. Ascendia Pharmaceuticals Recent Development Table 41. Bora Pharmaceutical CDMO Company Information Table 42. Bora Pharmaceutical CDMO Business Overview Table 43. Bora Pharmaceutical CDMO Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Bora Pharmaceutical CDMO Topical Drugs CDMO Product Portfolio Table 45. Bora Pharmaceutical CDMO Recent Development Table 46. Cambrex Corporation Company Information Table 47. Cambrex Corporation Business Overview Table 48. Cambrex Corporation Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Cambrex Corporation Topical Drugs CDMO Product Portfolio Table 50. Cambrex Corporation Recent Development Table 51. Contract Pharmaceuticals Limited Company Information Table 52. Contract Pharmaceuticals Limited Business Overview Table 53. Contract Pharmaceuticals Limited Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Contract Pharmaceuticals Limited Topical Drugs CDMO Product Portfolio Table 55. Contract Pharmaceuticals Limited Recent Development Table 56. DPT Laboratories LTD. Company Information Table 57. DPT Laboratories LTD. Business Overview Table 58. DPT Laboratories LTD. Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. DPT Laboratories LTD. Topical Drugs CDMO Product Portfolio Table 60. DPT Laboratories LTD. Recent Development Table 61. Lubrizol Life Science Company Information Table 62. Lubrizol Life Science Business Overview Table 63. Lubrizol Life Science Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Lubrizol Life Science Topical Drugs CDMO Product Portfolio Table 65. Lubrizol Life Science Recent Development Table 66. MedPharm Ltd. Company Information Table 67. MedPharm Ltd. Business Overview Table 68. MedPharm Ltd. Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. MedPharm Ltd. Topical Drugs CDMO Product Portfolio Table 70. MedPharm Ltd. Recent Development Table 71. PCI Pharma Services Company Information Table 72. PCI Pharma Services Business Overview Table 73. PCI Pharma Services Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. PCI Pharma Services Topical Drugs CDMO Product Portfolio Table 75. PCI Pharma Services Recent Development Table 76. Pierre Fabre Group Company Information Table 77. Pierre Fabre Group Business Overview Table 78. Pierre Fabre Group Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Pierre Fabre Group Topical Drugs CDMO Product Portfolio Table 80. Pierre Fabre Group Recent Development Table 81. Piramal Pharma Solutions Company Information Table 82. Piramal Pharma Solutions Business Overview Table 83. Piramal Pharma Solutions Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Piramal Pharma Solutions Topical Drugs CDMO Product Portfolio Table 85. Piramal Pharma Solutions Recent Development Table 86. North America Topical Drugs CDMO Market Size by Type (2021-2026) & (US$ Million) Table 87. North America Topical Drugs CDMO Market Size by Type (2027-2032) & (US$ Million) Table 88. North America Topical Drugs CDMO Market Size by Application (2021-2026) & (US$ Million) Table 89. North America Topical Drugs CDMO Market Size by Application (2027-2032) & (US$ Million) Table 90. North America Topical Drugs CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Topical Drugs CDMO Market Size by Country (2021-2026) Table 92. North America Topical Drugs CDMO Market Size by Country (2027-2032) Table 93. Europe Topical Drugs CDMO Market Size by Type (2021-2026) & (US$ Million) Table 94. Europe Topical Drugs CDMO Market Size by Type (2027-2032) & (US$ Million) Table 95. Europe Topical Drugs CDMO Market Size by Application (2021-2026) & (US$ Million) Table 96. Europe Topical Drugs CDMO Market Size by Application (2027-2032) & (US$ Million) Table 97. Europe Topical Drugs CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Topical Drugs CDMO Market Size by Country (2021-2026) Table 99. Europe Topical Drugs CDMO Market Size by Country (2027-2032) Table 100. China Topical Drugs CDMO Market Size by Type (2021-2026) & (US$ Million) Table 101. China Topical Drugs CDMO Market Size by Type (2027-2032) & (US$ Million) Table 102. China Topical Drugs CDMO Market Size by Application (2021-2026) & (US$ Million) Table 103. China Topical Drugs CDMO Market Size by Application (2027-2032) & (US$ Million) Table 104. Asia Topical Drugs CDMO Market Size by Type (2021-2026) & (US$ Million) Table 105. Asia Topical Drugs CDMO Market Size by Type (2027-2032) & (US$ Million) Table 106. Asia Topical Drugs CDMO Market Size by Application (2021-2026) & (US$ Million) Table 107. Asia Topical Drugs CDMO Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Topical Drugs CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Topical Drugs CDMO Market Size by Country (2021-2026) Table 110. Asia Topical Drugs CDMO Market Size by Country (2027-2032) Table 111. South America, Middle East & Africa Topical Drugs CDMO Market Size by Type (2021-2026) & (US$ Million) Table 112. South America, Middle East & Africa Topical Drugs CDMO Market Size by Type (2027-2032) & (US$ Million) Table 113. South America, Middle East & Africa Topical Drugs CDMO Market Size by Application (2021-2026) & (US$ Million) Table 114. South America, Middle East & Africa Topical Drugs CDMO Market Size by Application (2027-2032) & (US$ Million) Table 115. South America, Middle East & Africa Topical Drugs CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. South America, Middle East & Africa Topical Drugs CDMO Market Size by Country (2021-2026) Table 117. South America, Middle East & Africa Topical Drugs CDMO Market Size by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Topical Drugs CDMO Product Image Figure 2. Global Topical Drugs CDMO Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Topical Drugs CDMO Market Share by Type: 2025 VS 2032 Figure 4. Contract Development Image Figure 5. Contract Manufacturing Image Figure 6. Global Topical Drugs CDMO Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Topical Drugs CDMO Market Share by Application: 2025 VS 2032 Figure 8. Semi-Solid Formulations Image Figure 9. Solid Formulations Image Figure 10. Liquid Formulations Image Figure 11. Others Image Figure 12. Global Topical Drugs CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 14. Global Topical Drugs CDMO Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Topical Drugs CDMO Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Topical Drugs CDMO Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Topical Drugs CDMO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Topical Drugs CDMO Revenue Market Share by Type (2021-2032) Figure 21. Global Topical Drugs CDMO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Topical Drugs CDMO Revenue Market Share by Application (2021-2032) Figure 23. North America Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 24. North America Topical Drugs CDMO Market Share by Type (2021-2032) Figure 25. North America Topical Drugs CDMO Market Share by Application (2021-2032) Figure 26. North America Topical Drugs CDMO Market Share by Country (2021-2032) Figure 27. United States Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 28. Canada Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 30. Europe Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 31. Europe Topical Drugs CDMO Market Share by Type (2021-2032) Figure 32. Europe Topical Drugs CDMO Market Share by Application (2021-2032) Figure 33. Europe Topical Drugs CDMO Market Share by Country (2021-2032) Figure 34. Germany Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 35. France Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 37. Italy Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 38. Russia Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 40. China Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 41. China Topical Drugs CDMO Market Share by Type (2021-2032) Figure 42. China Topical Drugs CDMO Market Share by Application (2021-2032) Figure 43. Asia Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 44. Asia Topical Drugs CDMO Market Share by Type (2021-2032) Figure 45. Asia Topical Drugs CDMO Market Share by Application (2021-2032) Figure 46. Asia Topical Drugs CDMO Market Share by Country (2021-2032) Figure 47. Japan Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 51. India Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 52. Australia Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Topical Drugs CDMO Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Topical Drugs CDMO Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Topical Drugs CDMO Market Share by Country (2021-2032) Figure 57. Brazil Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 62. UAE Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 64. Chile Topical Drugs CDMO Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Contract Development
  • Contract Manufacturing
Applications
  • Semi-Solid Formulations
  • Solid Formulations
  • Liquid Formulations
  • Others
Companies covered
  • Ascendia Pharmaceuticals
  • Bora Pharmaceutical CDMO
  • Cambrex Corporation
  • Contract Pharmaceuticals Limited
  • DPT Laboratories LTD.
  • Lubrizol Life Science
  • MedPharm Ltd.
  • PCI Pharma Services
  • Pierre Fabre Group
  • Piramal Pharma Solutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Topical Drugs CDMO Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Contract Development
  5. 1.2.3 Contract Manufacturing
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Topical Drugs CDMO Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Semi-Solid Formulations
  9. 1.3.3 Solid Formulations
  10. 1.3.4 Liquid Formulations
  11. 1.3.5 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Topical Drugs CDMO Growth Trends by Region
  14. 1.5.1 Global Topical Drugs CDMO Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Topical Drugs CDMO Market Size by Region (2021-2026)
  16. 1.5.3 Topical Drugs CDMO Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Topical Drugs CDMO Market Dynamics
  1. 2.1 Topical Drugs CDMO Industry Trends
  2. 2.2 Topical Drugs CDMO Industry Drivers
  3. 2.3 Topical Drugs CDMO Industry Opportunities and Challenges
  4. 2.4 Topical Drugs CDMO Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Topical Drugs CDMO Revenue by Company (2021-2026)
  2. 3.2 Global Topical Drugs CDMO Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Topical Drugs CDMO Key Company Head office and Area Served
  4. 3.4 Global Topical Drugs CDMO Company, Product Type & Application
  5. 3.5 Global Topical Drugs CDMO Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Topical Drugs CDMO Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Topical Drugs CDMO Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Topical Drugs CDMO Tier 1, Tier 2, and Tier 3
4 Topical Drugs CDMO Market by Type
  1. 4.1 Global Topical Drugs CDMO Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Topical Drugs CDMO Market Size by Type (2021-2032)
  3. 4.3 Global Topical Drugs CDMO Market Size Share by Type (2021-2032)
5 Topical Drugs CDMO Market by Application
  1. 5.1 Global Topical Drugs CDMO Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Topical Drugs CDMO Market Size by Application (2021-2032)
  3. 5.3 Global Topical Drugs CDMO Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Ascendia Pharmaceuticals
  2. 6.1.1 Ascendia Pharmaceuticals Company Information
  3. 6.1.2 Ascendia Pharmaceuticals Business Overview
  4. 6.1.3 Ascendia Pharmaceuticals Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Ascendia Pharmaceuticals Topical Drugs CDMO Product Portfolio
  6. 6.1.5 Ascendia Pharmaceuticals Recent Developments
  7. 6.2 Bora Pharmaceutical CDMO
  8. 6.2.1 Bora Pharmaceutical CDMO Company Information
  9. 6.2.2 Bora Pharmaceutical CDMO Business Overview
  10. 6.2.3 Bora Pharmaceutical CDMO Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Bora Pharmaceutical CDMO Topical Drugs CDMO Product Portfolio
  12. 6.2.5 Bora Pharmaceutical CDMO Recent Developments
  13. 6.3 Cambrex Corporation
  14. 6.3.1 Cambrex Corporation Company Information
  15. 6.3.2 Cambrex Corporation Business Overview
  16. 6.3.3 Cambrex Corporation Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Cambrex Corporation Topical Drugs CDMO Product Portfolio
  18. 6.3.5 Cambrex Corporation Recent Developments
  19. 6.4 Contract Pharmaceuticals Limited
  20. 6.4.1 Contract Pharmaceuticals Limited Company Information
  21. 6.4.2 Contract Pharmaceuticals Limited Business Overview
  22. 6.4.3 Contract Pharmaceuticals Limited Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Contract Pharmaceuticals Limited Topical Drugs CDMO Product Portfolio
  24. 6.4.5 Contract Pharmaceuticals Limited Recent Developments
  25. 6.5 DPT Laboratories LTD.
  26. 6.5.1 DPT Laboratories LTD. Company Information
  27. 6.5.2 DPT Laboratories LTD. Business Overview
  28. 6.5.3 DPT Laboratories LTD. Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 DPT Laboratories LTD. Topical Drugs CDMO Product Portfolio
  30. 6.5.5 DPT Laboratories LTD. Recent Developments
  31. 6.6 Lubrizol Life Science
  32. 6.6.1 Lubrizol Life Science Company Information
  33. 6.6.2 Lubrizol Life Science Business Overview
  34. 6.6.3 Lubrizol Life Science Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Lubrizol Life Science Topical Drugs CDMO Product Portfolio
  36. 6.6.5 Lubrizol Life Science Recent Developments
  37. 6.7 MedPharm Ltd.
  38. 6.7.1 MedPharm Ltd. Company Information
  39. 6.7.2 MedPharm Ltd. Business Overview
  40. 6.7.3 MedPharm Ltd. Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 MedPharm Ltd. Topical Drugs CDMO Product Portfolio
  42. 6.7.5 MedPharm Ltd. Recent Developments
  43. 6.8 PCI Pharma Services
  44. 6.8.1 PCI Pharma Services Company Information
  45. 6.8.2 PCI Pharma Services Business Overview
  46. 6.8.3 PCI Pharma Services Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 PCI Pharma Services Topical Drugs CDMO Product Portfolio
  48. 6.8.5 PCI Pharma Services Recent Developments
  49. 6.9 Pierre Fabre Group
  50. 6.9.1 Pierre Fabre Group Company Information
  51. 6.9.2 Pierre Fabre Group Business Overview
  52. 6.9.3 Pierre Fabre Group Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Pierre Fabre Group Topical Drugs CDMO Product Portfolio
  54. 6.9.5 Pierre Fabre Group Recent Developments
  55. 6.10 Piramal Pharma Solutions
  56. 6.10.1 Piramal Pharma Solutions Company Information
  57. 6.10.2 Piramal Pharma Solutions Business Overview
  58. 6.10.3 Piramal Pharma Solutions Topical Drugs CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Piramal Pharma Solutions Topical Drugs CDMO Product Portfolio
  60. 6.10.5 Piramal Pharma Solutions Recent Developments
7 North America
  1. 7.1 North America Topical Drugs CDMO Market Size (2021-2032)
  2. 7.2 North America Topical Drugs CDMO Market Size by Type
  3. 7.2.1 North America Topical Drugs CDMO Market Size by Type (2021-2026)
  4. 7.2.2 North America Topical Drugs CDMO Market Size by Type (2027-2032)
  5. 7.2.3 North America Topical Drugs CDMO Market Share by Type (2021-2032)
  6. 7.3 North America Topical Drugs CDMO Market Size by Application
  7. 7.3.1 North America Topical Drugs CDMO Market Size by Application (2021-2026)
  8. 7.3.2 North America Topical Drugs CDMO Market Size by Application (2027-2032)
  9. 7.3.3 North America Topical Drugs CDMO Market Share by Application (2021-2032)
  10. 7.4 North America Topical Drugs CDMO Market Size by Country
  11. 7.4.1 North America Topical Drugs CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Topical Drugs CDMO Market Size by Country (2021-2026)
  13. 7.4.3 North America Topical Drugs CDMO Market Size by Country (2027-2032)
  14. 7.4.4 North America Topical Drugs CDMO Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Topical Drugs CDMO Market Size (2021-2032)
  2. 8.2 Europe Topical Drugs CDMO Market Size by Type
  3. 8.2.1 Europe Topical Drugs CDMO Market Size by Type (2021-2026)
  4. 8.2.2 Europe Topical Drugs CDMO Market Size by Type (2027-2032)
  5. 8.2.3 Europe Topical Drugs CDMO Market Share by Type (2021-2032)
  6. 8.3 Europe Topical Drugs CDMO Market Size by Application
  7. 8.3.1 Europe Topical Drugs CDMO Market Size by Application (2021-2026)
  8. 8.3.2 Europe Topical Drugs CDMO Market Size by Application (2027-2032)
  9. 8.3.3 Europe Topical Drugs CDMO Market Share by Application (2021-2032)
  10. 8.4 Europe Topical Drugs CDMO Market Size by Country
  11. 8.4.1 Europe Topical Drugs CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Topical Drugs CDMO Market Size by Country (2021-2026)
  13. 8.4.3 Europe Topical Drugs CDMO Market Size by Country (2027-2032)
  14. 8.4.4 Europe Topical Drugs CDMO Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Topical Drugs CDMO Market Size (2021-2032)
  2. 9.2 China Topical Drugs CDMO Market Size by Type
  3. 9.2.1 China Topical Drugs CDMO Market Size by Type (2021-2026)
  4. 9.2.2 China Topical Drugs CDMO Market Size by Type (2027-2032)
  5. 9.2.3 China Topical Drugs CDMO Market Share by Type (2021-2032)
  6. 9.3 China Topical Drugs CDMO Market Size by Application
  7. 9.3.1 China Topical Drugs CDMO Market Size by Application (2021-2026)
  8. 9.3.2 China Topical Drugs CDMO Market Size by Application (2027-2032)
  9. 9.3.3 China Topical Drugs CDMO Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Topical Drugs CDMO Market Size (2021-2032)
  2. 10.2 Asia Topical Drugs CDMO Market Size by Type
  3. 10.2.1 Asia Topical Drugs CDMO Market Size by Type (2021-2026)
  4. 10.2.2 Asia Topical Drugs CDMO Market Size by Type (2027-2032)
  5. 10.2.3 Asia Topical Drugs CDMO Market Share by Type (2021-2032)
  6. 10.3 Asia Topical Drugs CDMO Market Size by Application
  7. 10.3.1 Asia Topical Drugs CDMO Market Size by Application (2021-2026)
  8. 10.3.2 Asia Topical Drugs CDMO Market Size by Application (2027-2032)
  9. 10.3.3 Asia Topical Drugs CDMO Market Share by Application (2021-2032)
  10. 10.4 Asia Topical Drugs CDMO Market Size by Country
  11. 10.4.1 Asia Topical Drugs CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Topical Drugs CDMO Market Size by Country (2021-2026)
  13. 10.4.3 Asia Topical Drugs CDMO Market Size by Country (2027-2032)
  14. 10.4.4 Asia Topical Drugs CDMO Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Topical Drugs CDMO Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Topical Drugs CDMO Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Topical Drugs CDMO Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Topical Drugs CDMO Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Topical Drugs CDMO Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Topical Drugs CDMO Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Topical Drugs CDMO Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Topical Drugs CDMO Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Topical Drugs CDMO Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Topical Drugs CDMO Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Topical Drugs CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Topical Drugs CDMO Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Topical Drugs CDMO Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Topical Drugs CDMO Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst